Fulcrum Therapeutics (FULC) EPS (Basic) (2018 - 2026)
Fulcrum Therapeutics' (FULC) quarterly EPS (Basic) came in at -$0.66 in Q1 2026, down 39.2% year-on-year from -$1.08 in Q1 2025, and up 99.95% on a QoQ basis from -$1328.3 in Q4 2025.
Fulcrum Therapeutics (FULC) EPS (Basic) (2018 - 2026) Analysis & Trends
Fulcrum Therapeutics (FULC) has 9 years of EPS (Basic) data on file, last reported at -$0.66 in Q1 2026.
- On a quarterly basis, EPS (Basic) fell 39.2% year-over-year to -$0.66 in Q1 2026; TTM through Mar 2026 was -$2.24, a 108.79% decrease from a year earlier, with the FY2025 full-year figure at -$2544.9, down 114.95% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.66, up from -$1328.3 in the prior quarter.
- Over the last five years, EPS (Basic) for FULC reached as high as $0.89 in Q2 2024 and fell as low as -$4277.7 in Q4 2022.
- Historically, EPS (Basic) has averaged -$662.04 across 5 years, with a median of -$388.48 in 2023.
- Across the five-year window, EPS (Basic) slumped 21999.2% in 2023 and surged 100.23% in 2024, its largest moves.
- Year by year, EPS (Basic) stood at -$4277.7 in 2022, then jumped by 83.56% to -$703.08 in 2023, then sank by 63.91% to -$1152.4 in 2024, then decreased by 15.26% to -$1328.3 in 2025, then surged by 99.95% to -$0.66 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$0.66 in Q1 2026, -$1328.3 in Q4 2025, and -$0.31 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Fulcrum Therapeutics | 285.43 Mn | 285.43 Mn | - | -0.66 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.66 |
| Dec 31, 2025 | -1,328.26 |
| Sep 30, 2025 | -0.31 |
| Jun 30, 2025 | -0.28 |
| Mar 31, 2025 | -0.47 |
| Dec 31, 2024 | -1,152.41 |
| Sep 30, 2024 | -0.35 |
| Jun 30, 2024 | 0.89 |
| Mar 31, 2024 | -1,052.51 |
| Dec 31, 2023 | -703.08 |
| Sep 30, 2023 | -388.48 |
| Jun 30, 2023 | -384.88 |
| Mar 31, 2023 | -511.08 |
| Dec 31, 2022 | -4,277.66 |
| Sep 30, 2022 | -586.07 |
| Jun 30, 2022 | -866.76 |
| Mar 31, 2022 | -2.31 |
| Dec 31, 2021 | -1,440.88 |
| Sep 30, 2021 | -2,635.30 |
| Jun 30, 2021 | -1,163.99 |